Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Evaluating Cabazitaxel in Patients With Brain Metastasis Secondary to Breast and Non-small Cell Lung Cancer

NCT01913067 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT01913067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01913067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Evaluating Cabazitaxel in Patients With Brain Metastasis Secondary to Breast and Non-small Cell Lung Cancer
Lead sponsor
Jules Bordet Institute
Phase
Phase 2
Overall status
Withdrawn
Start date
September 30, 2013
Completion date
September 30, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastasis, breast cancer, non small cell lung cancer